From: Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms
 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Characteristics | HR (95% CI) | p-value | HR (95% CI) | p-value |
Gender | ||||
 (male vs female) | 0.862 (0.595–1.249) | 0.434 |  |  |
Age, years | ||||
 (≥median vs. < median) | 1.012 (0.998–1.027) | 0.102 |  |  |
Risk factors | ||||
 (alcohol consumption vs non-alcohol consumption) | 1.114 (0.828–1.499) | 0.476 |  |  |
Histologic grade | ||||
 (G1 + G2 vs G3 + G4) | 1.215 (0.879–1.414) | 0.0389* |  |  |
Clinical stage | ||||
 (stage I + II vs stage III + IV) | 1.381 (1.149–1.660) | 0.000* |  |  |
Pathologic T stage (present vs. absent) | 1.673 (1.393–2.010) | 0.000* | 1.645 (1.192–2.269) | 0.002* |
Pathologic N stage (present vs. absent) | 0.140 (0.045–0.442) | 0.007* | 0.169 (0.038–0.740) | 0.018* |
Pathologic M stage (present vs. absent) | 0.089 (0.0221–0.362) | 0.000* | 0.335 (0.10–1.126) | 0.070* |
CENPM | ||||
 (≥median vs. < median) | 1.043 (1.014–1.073) | 0.003* | 1.025 (0.799–1.057) | 0.032* |